NT Scan (Nuchal Translucency Scan): Purpose, Timing, Accuracy and What the Result Means

Key takeaways

• Screening, not diagnosis: the NT scan gives a probability, never a yes-or-no answer about a chromosomal condition.
• Timing is fixed: the measurement is valid only when the crown-rump length is roughly 45-84 mm, typically 11-13 weeks.
• Best used in combination: NT alone is less informative than the combined test (NT plus free beta-hCG and PAPP-A).
• A normal NT does not exclude Down syndrome, other genetic conditions, or structural anomalies.
• In India, every obstetric ultrasound is governed by the PC-PNDT Act 1994: the sex of the foetus cannot be revealed or asked for.

At a glance

Also known as

• Nuchal translucency scan, NT scan, NT sonography
• First trimester screening scan, 11-13 week scan, "double marker scan" when done with the blood test (the blood test itself is the double marker)
• USG for NT, NT sonography, "neck fluid scan" in common speech
• Combined first trimester screening (CFTS) when ultrasound and blood markers are reported together

What the NT scan is

Every foetus has a small fluid-filled space under the skin at the back of the neck in early pregnancy. On ultrasound this appears as a dark band and is called the nuchal translucency. The NT scan measures the maximum thickness of that band in a precise mid-sagittal view, with the foetus in a neutral position and the image magnified so the head and upper chest fill the screen.

A thicker nuchal translucency is associated statistically with chromosomal conditions, congenital heart disease and some genetic syndromes. Most babies with a mildly increased NT are healthy. The measurement is not a diagnosis; it is one input into a risk calculation that also uses gestational age, maternal age, and usually blood markers.

The same appointment usually confirms the number of foetuses, chorionicity in twins, cardiac activity, accurate dating from crown-rump length, and an early look at foetal anatomy.

Why the NT scan is done

• Risk estimation for trisomy 21, 18 and 13 early enough for further testing to be arranged unhurriedly.
• Accurate dating of the pregnancy, which affects every later scan and screening result.
• Early anatomical survey: some major structural anomalies are visible by 13 weeks.
• Twin pregnancy assessment: chorionicity is easiest to determine in the first trimester and strongly influences care.
• Flagging cardiac risk: a markedly increased NT with normal chromosomes still warrants a detailed foetal echocardiogram later.

Who should consider an NT scan

First-trimester screening is offered to all pregnant women, not only those considered high risk. Most babies with Down syndrome are born to women under 35, simply because more pregnancies occur in that age group. The scan is elective, you may accept or decline it after counselling.

• Any woman in the 11-13⁺⁶ week window who wants information about chromosomal risk.
• Age 35 or above at delivery, where baseline risk is higher.
• Previous pregnancy affected by a chromosomal or genetic condition.
• Family history of congenital heart disease or genetic syndromes.
• Consanguineous marriage: relevant in parts of India, though NT screening targets chromosomal rather than most recessive conditions.
• Pregestational diabetes or maternal epilepsy on medication, where structural anomaly risk is higher, here the NT scan is an early look, not a substitute for the anomaly scan.

Women who have already had cell-free DNA (NIPT) may still be advised an 11-13 week ultrasound, because NIPT gives no information about foetal structure, dating or twins.

What the NT scan cannot detect or exclude

This is the section most patients need and most pages omit.

• The NT scan cannot diagnose Down syndrome. Only chorionic villus sampling or amniocentesis with karyotype or microarray can confirm or exclude a chromosomal condition.
• A normal NT does not exclude trisomy 21. A proportion of affected pregnancies have a normal measurement. Combined screening detects most, not all.
• Single-gene disorders are not screened. Thalassaemia, sickle cell disease, cystic fibrosis, spinal muscular atrophy, haemophilia and Duchenne muscular dystrophy are invisible to the NT scan. Thalassaemia carrier screening in both partners is a separate and, in India, highly relevant test.
• Most structural anomalies are not assessable at 12 weeks. Cleft lip and palate, many cardiac defects, renal anomalies, club foot and brain malformations are usually evaluated at the 18-22 week anomaly scan.
• Neural tube defects are not reliably screened by NT measurement alone.
• Autism, intellectual disability of unknown cause, cerebral palsy and later-onset conditions are not detectable.
• Placental complications, growth restriction and preterm birth are not predicted by the NT measurement itself, although PAPP-A from the same screen carries some association.
• Outside the 45-84 mm crown-rump length window the measurement is not valid and cannot simply be done late.

A result described as "low risk" or "screen negative" means no increased probability was identified on that day with those inputs. It is not the same as "excluded". If concerns arise later, or a subsequent scan raises a question, speak to your obstetrician rather than relying on the earlier normal report.

Related but different examinations

No single test is superior across the board. NIPT performs better than combined screening for trisomy 21 detection, but only the ultrasound sees the baby, and only an invasive test gives a diagnosis.

How to prepare

Preparation instructions differ between units and ultrasound machines. Follow the written instruction your scanning centre gives you; it takes precedence over general advice.

• Bladder: many centres ask for a moderately full bladder at this gestation to lift the uterus into view; others do not. Ask when booking.
• Fasting: not required.
• Documents: carry your last menstrual period date, any earlier scan reports, prescription list and identity proof. Under the PC-PNDT Act, Indian centres must record your details on Form F.
• Clothing: two-piece clothing allows easy access to the lower abdomen.
• Blood test coordination: if the double marker test is part of your screening, ask whether blood should be drawn before or after the scan so both results can be combined.
• Bring your partner or a support person if you would like company for the discussion of results.

If you have a fluid restriction, heart failure or advanced kidney disease

Do not load up on water to fill the bladder without checking. Tell the centre in advance; alternative approaches, including a transvaginal scan, are usually possible.

If you have diabetes on insulin or other glucose-lowering medicines

No fasting is needed for the NT scan, so take your meals and medicines as usual. If any accompanying blood test requires fasting, ask your prescriber how to time your medication, do not skip or alter doses on your own.

If a transvaginal scan is suggested

A transvaginal approach is sometimes needed when the uterus is retroverted, when abdominal wall thickness limits image quality, or when the foetus is in a difficult position. The scan requires an empty bladder and your consent, and you may decline.

What happens during the NT scan

You lie on your back with the lower abdomen exposed. Warm gel is applied and the sonologist moves a probe over the abdomen. The room lights are often dimmed to improve screen contrast.

The operator first confirms cardiac activity and measures the crown-rump length to check that the gestation is within the valid window. A magnified mid-sagittal image of the foetal head and upper thorax is then obtained with the neck in neutral position, and the nuchal translucency is measured at its widest point. Several measurements are usually taken and the largest valid one is used.

Additional markers such as nasal bone presence, ductus venosus flow and tricuspid regurgitation may be assessed where the operator is trained and accredited to do so. A brief early anatomy survey follows.

How long the NT scan takes

Image acquisition typically takes 20-30 minutes. If the foetus is lying face down, curled, or moving little, the sonologist may ask you to walk about, cough, or empty your bladder and return, which can extend the appointment to 45-60 minutes. Occasionally a repeat visit on another day is needed. This is common and does not by itself indicate a problem.

You may feel firm probe pressure, especially over a full bladder. The scan is not painful.

Under the PC-PNDT Act

The sex of the foetus will not be disclosed at any stage, and it is an offence to request it. Registered centres display this notice and maintain statutory records. This has no bearing on the quality or completeness of the medical information you receive.

Understanding your NT scan report

An NT report usually contains three elements.

• Crown-rump length in millimetres: confirms gestational age and validates the measurement window.
• Nuchal translucency in millimetres, often also expressed as a multiple of the median (MoM) or a percentile for that crown-rump length. The same millimetre value means different things at 11 weeks and at 13 weeks, which is why the raw number alone is not interpretable.
• A risk ratio such as 1 in 20 or 1 in 5,000, generated by accredited software combining NT, maternal age, gestation, and where available the double marker results.

Risk ratios are often misread. "1 in 250" means that out of 250 pregnancies with identical inputs, one would be expected to be affected, that is, roughly a 0.4% chance and about a 99.6% chance of being unaffected. A larger second number means a lower risk.

Laboratories and units use different cut-offs to define "screen positive", and the threshold may differ between software packages. Your report will state the cut-off used. Do not compare your ratio against a number you have read elsewhere.

A screen-positive result does not mean the baby has a chromosomal condition; most screen-positive pregnancies turn out to be unaffected. It means further testing should be discussed. Options include NIPT (another screen, more accurate for common trisomies) or a diagnostic test such as CVS or amniocentesis.

Only the obstetrician or foetal medicine specialist who ordered the scan can interpret the report in the context of your history, your previous pregnancies and your preferences. Results vary depending on individual clinical circumstances.

Why this page does not print a normal range table

NT "normal" is defined against gestation-specific reference curves built into validated software, not against a single fixed millimetre figure. Publishing a simplified cut-off encourages self-diagnosis from a number that is only meaningful alongside crown-rump length, maternal age and biochemistry. Ask your clinician what your measurement means for your pregnancy.

When NT scan results can be misleading

Factors that can falsely raise the measurement or the calculated risk

• Foetal neck hyperextension: an extended neck can add to the apparent thickness.
• Including the amniotic membrane in the measurement when the membrane lies close to the foetal back.
• Incorrect caliper placement or inadequate magnification, which is why operator accreditation matters.
• Wrong dating: if the pregnancy is more advanced than assumed, the measurement is judged against the wrong reference curve.
• A genuinely increased NT with normal chromosomes, which may reflect cardiac disease, a genetic syndrome, or nothing at all; many such babies are entirely healthy.

Factors that can falsely lower the measurement or understate risk

• Foetal neck flexion (chin on chest), which can compress the translucency.
• Poor image resolution or insufficient magnification, blurring the boundaries.
• Measuring early in the window when the translucency is still small.
• Affected pregnancies with a normal NT: a real and unavoidable limitation of screening.

Factors that affect reliability in either direction

• Increased maternal abdominal wall thickness, reducing image quality; a transvaginal approach may help.
• Twin pregnancy: risk calculation differs, and in monochorionic twins a discordant NT may reflect twin-to-twin issues rather than chromosomal risk.
• Pregnancy after IVF or with a donor oocyte: maternal age inputs must be adjusted for the oocyte donor's age.
• Vanishing twin: biochemical markers become unreliable and NT-only screening may be preferred.
• Uterine fibroids or an unusual uterine position, limiting access to the correct plane.

Risks and safety

Transabdominal NT ultrasound

Diagnostic obstetric ultrasound uses sound waves, not ionising radiation, and has been used in pregnancy for decades without evidence of harm to the foetus when performed for a medical indication by trained staff using the ALARA principle (as low as reasonably achievable output and exposure time). No procedure can be described as risk-free, but the recognised risks of a diagnostic NT scan are very low. Mild discomfort from probe pressure on a full bladder is the usual complaint.

Transvaginal ultrasound

A transvaginal scan may cause brief discomfort or light spotting. It is generally avoided where there is active bleeding of uncertain cause, ruptured membranes, or where you decline it. Tell the operator if you have pain during the examination.

Non-medical "keepsake" ultrasound

Prolonged scanning purely for souvenir images or videos is not recommended, as it increases exposure time without clinical benefit.

Downstream procedures

The NT scan itself carries no procedural risk to the pregnancy, but a screen-positive result may lead to CVS or amniocentesis, which do carry a small procedure-related miscarriage risk. That risk applies to the invasive test, not to the scan. Discuss the specific figures at your centre before consenting.

Psychological effect

Screening can cause anxiety, particularly with a borderline or screen-positive result during the waiting period for further tests. Pre-test counselling about what the NT scan can and cannot tell you reduces this.

Special situations

Twin and higher-order pregnancies

Each foetus is measured separately. In dichorionic twins a risk is generated per foetus; in monochorionic twins risk is usually assigned to the pregnancy as a whole. Biochemical markers are less reliable in multiples. NIPT performance is also lower in twins. Discuss the pathway with a foetal medicine specialist.

Pregnancy after IVF or with donor eggs

The software must be told the oocyte age and the conception method, otherwise the risk estimate will be wrong. Carry your fertility treatment summary to the appointment.

Women aged 35 and above

Baseline chromosomal risk rises with age, so more women in this group will screen positive. Age alone is not a reason to skip screening or to proceed straight to an invasive test; discuss NIPT and diagnostic options.

Pre-existing diabetes, thyroid disease or epilepsy

These conditions do not prevent the NT scan. They may alter biochemical marker interpretation and increase the importance of the later anomaly scan and foetal echocardiogram. Continue prescribed medicines and raise any concerns with your prescriber rather than stopping treatment.

Raised BMI or increased abdominal wall thickness

Image quality may be reduced and the scan may take longer or need a transvaginal approach or a repeat visit. This is a technical limitation, not a reflection on you.

Adolescent and older first-time mothers

Counselling should be unhurried and in a language you are comfortable with. You may ask for a translator or bring a family member.

If you decline screening

Declining first-trimester screening is a legitimate choice. A dating and viability ultrasound may still be recommended, and the 18-22 week anomaly scan remains important.

The NT scan in the Indian context

• PC-PNDT Act 1994: all obstetric ultrasound must be performed at a registered facility by a qualified, registered person. Foetal sex determination and disclosure are prohibited. Form F is completed for every scan. These requirements protect against sex-selective practice and are non-negotiable.
• Medical Termination of Pregnancy (Amendment) Act 2021 governs decisions that may follow a diagnostic result; substantial foetal abnormality is assessed by a Medical Board beyond the stated gestational limits. Discuss the current legal position with your obstetrician.
• Operator accreditation matters more than machine brand. NT measurement is highly technique-dependent. Ask whether the sonologist performing your scan holds current accreditation for NT measurement and audits their images.
• Thalassaemia and sickle cell carrier screening are particularly relevant in India and are entirely separate from the NT scan. Beta-thalassaemia carrier rates are appreciable in several communities. If both partners are carriers, prenatal diagnosis is offered, the NT scan will not detect this.
• Consanguinity raises the risk of autosomal recessive conditions, which NT screening does not address. Genetic counselling is the appropriate route.
• Access and timing: the 11-13⁺⁶ week window is narrow. Late booking of antenatal care is a common reason the NT scan is missed in India; second-trimester quadruple marker screening is then the alternative.
• Terminology you will hear: "NT sonography", "double marker", "level 1 scan" for the early scan and "level 2" or "TIFFA" for the anomaly scan. Terms are used loosely, ask exactly which examination has been booked.

Cost and insurance in India

Charges vary widely between cities, between government and private facilities, and between a standalone NT scan and a combined package with the double marker blood test. Costs are indicative only and change frequently; confirm the current price and what it includes with the facility before booking.

Factors that influence cost:

• Whether the price covers ultrasound alone or the combined screening with biochemistry and software-generated risk.
• Whether additional markers (nasal bone, ductus venosus, tricuspid flow) are assessed by a foetal medicine specialist.
• City tier and whether the centre is a hospital, a diagnostic chain or a standalone clinic.
• Need for a repeat visit if the foetal position prevents measurement.
• Whether a consultation or genetic counselling session is bundled in.
• Government schemes and public hospital antenatal services, where charges may be nominal or nil.

Insurance: routine antenatal outpatient investigations are frequently excluded from standard Indian health insurance policies, which typically cover inpatient hospitalisation. Some maternity riders and corporate group policies do include antenatal tests, often after a waiting period. Check your policy wording and pre-authorisation requirements with your insurer rather than assuming cover.

Myths and facts

Frequently asked questions

Is the NT scan compulsory in pregnancy?

No. First-trimester screening is offered, not imposed. You may accept or decline after counselling about what the NT scan can and cannot tell you. Declining screening does not affect the rest of your antenatal care, and a dating scan and the 18-22 week anomaly scan are usually still recommended.

What happens if I miss the 13⁺⁶ week window?

The nuchal translucency cannot be measured reliably after that point. Alternatives include the quadruple marker test at about 15-20 weeks, or cell-free DNA screening, which can be performed later in pregnancy. Speak to your obstetrician promptly so the alternative pathway is arranged without further delay.

Does a slightly increased NT always mean a problem?

No. Many babies with a mildly increased nuchal translucency have normal chromosomes and develop normally. A markedly increased measurement carries a higher association with chromosomal conditions and congenital heart disease, and usually prompts further testing plus a foetal echocardiogram later in pregnancy.

Do I need a full bladder for the NT scan?

It depends on the unit and the machine. Some centres request a moderately full bladder to improve the view at 11-13 weeks; others do not. Ask when you book. If you have a fluid restriction, heart failure or advanced kidney disease, tell them before drinking large volumes.

Should I have NIPT instead of the NT scan?

The two answer different questions. NIPT detects common trisomies more accurately from maternal blood but shows nothing about foetal anatomy, dating or twins. The NT scan does both an ultrasound assessment and a risk calculation. Many clinicians recommend the ultrasound regardless of whether NIPT is chosen.

Why was I asked to come back another day?

If the baby lies face down, curls up, or stays still, the correct mid-sagittal plane may be unobtainable. Walking around, coughing or emptying the bladder often helps; occasionally a repeat visit is needed. A rescheduled scan is a technical matter and is not itself a sign of a problem.

Can the NT scan detect thalassaemia or sickle cell disease?

No. These are single-gene disorders and are invisible on ultrasound. Carrier screening of both partners by complete blood count and haemoglobin electrophoresis or HPLC is the appropriate test, and is especially relevant in India. If both partners are carriers, prenatal diagnostic testing is discussed separately.

How long before I get the report?

The ultrasound measurements are often discussed at the end of the appointment. The combined risk ratio needs the double marker blood results and software calculation, so the final report typically takes longer. Ask your centre for their expected timeline when you book, as this varies considerably.

Will the scan hurt the baby or cause miscarriage?

Diagnostic ultrasound has not been shown to cause miscarriage or foetal harm when performed for a medical indication by trained staff. Any small procedure-related miscarriage risk you may have read about relates to invasive tests such as CVS and amniocentesis, not to the NT scan itself.

Sources

• Fetal Medicine Foundation, standards for nuchal translucency measurement and operator accreditation.
• International Society of Ultrasound in Obstetrics and Gynecology (ISUOG), practice guidelines for the performance of first-trimester foetal ultrasound.
• Royal College of Obstetricians and Gynaecologists and NICE antenatal care guidance, first-trimester combined screening.
• American College of Obstetricians and Gynecologists, Practice Bulletin on screening for foetal chromosomal abnormalities.
• Pre-conception and Pre-natal Diagnostic Techniques (Prohibition of Sex Selection) Act, 1994, Government of India, with subsequent rules and amendments.
• Medical Termination of Pregnancy (Amendment) Act, 2021, Government of India.
• Federation of Obstetric and Gynaecological Societies of India (FOGSI), good clinical practice recommendations on antenatal screening and thalassaemia prevention.